AstraZeneca Revenue TTM:
27.01B for March 31, 2013AstraZeneca Historical Revenue TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 27.01B |
| Dec. 31, 2012 | 27.97B |
| Sept. 30, 2012 | 29.35B |
| June 30, 2012 | 30.88B |
| March 31, 2012 | 32.65B |
| Dec. 31, 2011 | 33.59B |
| Sept. 30, 2011 | 33.55B |
| June 30, 2011 | 33.24B |
| March 31, 2011 | 32.98B |
| Dec. 31, 2010 | 33.27B |
| Sept. 30, 2010 | 33.60B |
| June 30, 2010 | 33.90B |
| March 31, 2010 | 33.68B |
| Dec. 31, 2009 | 32.80B |
| Sept. 30, 2009 | 32.05B |
| June 30, 2009 | 31.63B |
| March 31, 2009 | 31.62B |
| Dec. 31, 2008 | 31.60B |
| Sept. 30, 2008 | 31.58B |
| June 30, 2008 | 30.95B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenues (TTM)
AZN Revenue TTM Benchmarks
| Companies | |
|---|---|
| Sanofi | 45.21B |
| GlaxoSmithKline | 41.42B |
| Pfizer | 57.60B |
AZN Revenue TTM Rankings
| Overall |
97th percentile 168 of 8002 |
| Sector |
97th percentile 18 of 684 in Healthcare |
| Industry |
87th percentile 7 of 54 in Drug Manufacturers - Major |
AZN Revenue TTM Range, Past 5 Years
| Minimum | 27.01B | Mar 2013 |
| Maximum | 33.90B | Jun 2010 |
| Average | 31.90B |
